Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

UFS gets support for improving university access and success in South Africa
2013-10-24

 

Members of the SASSE Research team are from left: Carike Jordaan, Dr Francois Strydom, Lana Swart, Seisho Gaboutlwelweboutlwelwakemo, Michael Henn en Katleho Nyaile.
Photo: Supplied
24 October 2013

The university’s Centre of Teaching and Learning (CTL) received a grant for US$820 000 (about R8 million) from the Kresge Foundation for their South African Survey of Student Engagement (SASSE) research team.

The SASSE research team is committed to furthering student access with success by promoting quality teaching and learning institutionally and promoting collective impact around student success nationally.

Through this three-year project, the SASSE team aims to provide a range of deeply contextualised and globally benchmarked student engagement measures that can be used at institutional and module/course level for the South African context. The data from these measures can be used to improve the quality of undergraduate teaching and learning, and participating institutions will have access to appropriate capacity development interventions to empower them to use the data to promote evidence-based change in their institutions.

Dr Francois Strydom, Academic Director at the CTL, says the lessons from this higher-education project could be used to develop a stronger post-school sector which could help the country to deal with the massive challenge of youth unemployment; thereby promoting equity, social justice and a prosperous democracy in South Africa.

The Kresge Foundation is a private philanthropic foundation in the United States, which is focused on creating opportunity for low-income people through various programmes. This three-year project forms part of the Kresge Foundation’s Education Programme, which focuses on promoting access and success at South African universities. Therefore the SASSE project aims to contribute to the Kresge-sponsored Access and Success in Higher Education in South Africa (ASHESA), to promote a national conversation on improving student success.

In January this year, the university was one of four South African universities selected to take part in a multi-million rand programme to bolster private fund-raising and advancement efforts. For this programme the UFS was granted US$640 000 (about R5,6 million) over a period of five years.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept